Fueled by the expertise of a team of international specialist authors, this first reference on the booming topic covers everything a drug researcher needs to know about targeting epigenetic mechanisms of disease. The first part of the book surveys current methodologies for finding and validating drug candidates that act via epigenetic mechanisms. The second part systematically surveys known and suspected drug targets within the epigenetic machinery, including the discovery and development of vorinostat, the first marketed ...
Read More
Fueled by the expertise of a team of international specialist authors, this first reference on the booming topic covers everything a drug researcher needs to know about targeting epigenetic mechanisms of disease. The first part of the book surveys current methodologies for finding and validating drug candidates that act via epigenetic mechanisms. The second part systematically surveys known and suspected drug targets within the epigenetic machinery, including the discovery and development of vorinostat, the first marketed epigenetic drug.
Read Less
Add this copy of Epigenetic Targets in Drug Discovery to cart. $145.54, Sold by Books International rated 4.0 out of 5 stars, ships from Toronto, ON, CANADA, published 2009 by Wiley-Vch.
Add this copy of Epigenetic Targets in Drug Discovery to cart. $182.98, new condition, Sold by Media Smart rated 4.0 out of 5 stars, ships from Hawthorne, CA, UNITED STATES, published 2009 by John Wiley & Sons.
Add this copy of Epigenetic Targets in Drug Discovery to cart. $189.72, new condition, Sold by discount_scientific_books rated 3.0 out of 5 stars, ships from Sterling Heights, MI, UNITED STATES, published 2009 by Wiley-Vch.
Add this copy of Epigenetic Targets in Drug Discovery to cart. $191.70, new condition, Sold by discount_scientific_books rated 3.0 out of 5 stars, ships from Sterling Heights, MI, UNITED STATES, published 2009 by Wiley-Vch.
